Showing results (261-270 of 317) with videos related to
Sort By:
Pageof 32
Blood Advances|January 31, 2024
Prognostic impact of cooccurring mutations in FLT3-ITD pediatric acute myeloid leukemiaKatherine Tarlock, Robert B Gerbing, Rhonda E Ries, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2022
Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio <i>FLT3</i>/ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031Jessica A Pollard, Todd A Alonzo, Robert Gerbing, et al.Blood|November 15, 2014
Subclonal mutations in SETBP1 confer a poor prognosis in juvenile myelomonocytic leukemiaElliot Stieglitz, Camille B Troup, Laura C Gelston, et al.Leukemia|February 15, 2019
Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemiaNicole A McNeer, John Philip, Heather Geiger, et al.Blood|May 5, 2021
CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children's Oncology GroupKatherine Tarlock, Adam J Lamble, Yi-Cheng Wang, et al.Cancers|April 27, 2024
Chromatin Profiles Are Prognostic of Clinical Response to Bortezomib-Containing Chemotherapy in Pediatric Acute Myeloid Leukemia: Results from the COG AAML1031 TrialAnneke D van Dijk, Fieke W Hoff, Yihua Qiu, et al.British Journal of Haematology|October 22, 2016
Genomics of primary chemoresistance and remission induction failure in paediatric and adult acute myeloid leukaemiaFiona C Brown, Paolo Cifani, Esther Drill, et al.Leukemia|March 28, 2013
NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression patternJ D E de Rooij, I H I M Hollink, S T C J M Arentsen-Peters, et al.Blood|September 22, 2020
Heat shock factor 1 (HSF1-pSer326) predicts response to bortezomib-containing chemotherapy in pediatric AML: a COG reportFieke W Hoff, Anneke D van Dijk, Yihua Qiu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2017
MicroRNA Expression-Based Model Indicates Event-Free Survival in Pediatric Acute Myeloid LeukemiaEmilia L Lim, Diane L Trinh, Rhonda E Ries, et al.Pageof 32